AbbVie Down Nearly 7%, on Track for Largest Percent Decrease Since September 2021 -- Data Talk
April 27 2023 - 10:46AM
Dow Jones News
AbbVie, Inc. (ABBV) is currently at $150.50, down $11.30 or
6.98%
--Would be lowest close since March 10, 2023, when it closed at
$149.71
--On pace for largest percent decrease since Sept. 1, 2021, when
it fell 7.05%
--Currently down two consecutive days; down 8.73% over this
period
--Worst two day stretch since the two days ending March 23,
2020, when it fell 9.23%
--Down 5.57% month-to-date; on pace for worst month since Jan.
2023, when it fell 8.58%
--Down 6.87% year-to-date
--Down 13.98% from its all-time closing high of $174.96 on April
8, 2022
--Down 3.72% from 52 weeks ago (April 28, 2022), when it closed
at $156.31
--Down 9.64% from its 52-week closing high of $166.55 on Jan. 6,
2023
--Up 12.14% from its 52-week closing low of $134.21 on Sept. 30,
2022
--Traded as low as $147.70; lowest intraday level since March
10, 2023, when it hit $147.47
--Down 8.71% at today's intraday low; largest intraday percent
decrease since April 29, 2022, when it fell as much as 10.48%
--Second worst performer in the S&P 500 today
All data as of 10:13:28 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 27, 2023 10:31 ET (14:31 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From May 2024 to Jun 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Jun 2023 to Jun 2024